Razi Vaccine and Serum Research Institute   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Karaj Iran (Islamic Republic of) (2000)

Organization Overview

First Clinical Trial
2007
NCT00429780
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Razi vaccine and serum Research Institue of Mashhd

Active Ingredients

Drugs in Phase 3 Trials (2)

bacille calmette-guerin (2 trials)

potassium alum (2 trials)

Drugs in Phase 2 Trials (3)

camel milk (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

ribavirin (virazole) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5